Lindsay launches the so-called smart pivot. By combining advanced agronomy with predictive machine diagnostics, Lindsay’s smart pivot detects crop health issues and optimises irrigation at scale. Advanced machine monitoring identifies wear and alerts dealer service technicians.
Lindsay’s smart pivot works with two smart streams – FieldNET advanced agronomics and Zimmatic machine health. Lindsay says it is designed to support healthier crops and more sustainable farming practices while reducing risk and operational downtime, significantly expanding what the traditional pivot is capable of. Several of the smart pivot features are the outcome of collaboration and joint development with strategic partners, including Taranis.
The smart pivot uses sensors, high-resolution imagery and advanced algorithms to improve crop health – both above and below the crop canopy – with features including:
Lindsay is also introducing machine health capabilities that include:
Text continues underneath video
“The smart pivot introduces the next era of mechanised irrigation,” said Gustavo Oberto, president of irrigation at Lindsay. “It delivers never-before-seen insights and efficiency to a grower’s operation, changing the way they – and the industry – look at and use center pivots.”
Oberto described the smart pivot as a “self-aware, always-there robot in the field, capable of at-scale crop health management, and ground-breaking machine health features. The smart pivot virtually takes care of itself – and your crops,” he said.
Taranis brings its precision scouting solution to this partnership, allowing the smart pivot to pinpoint challenges across the entire field for focused management. It empowers growers to make more informed, timely replant, crop nutrition and protection decisions that optimise yields.
“Our precision scouting platform captures comprehensive intel from the field and delivers easy-to-digest insights for Lindsay’s smart pivot,” said Ofir Schlam, CEO and Founder of Taranis.
Smart pivot features are in development now. Field testing is underway, and a limited commercial offering will begin in the spring of 2021 in North America, with a broader market release expected in spring 2022.